Clinical Trial Update: Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients [NA]

View source ↗

Summary

A Sun Yat-sen University-sponsored clinical trial is currently recruiting to evaluate whether oral immunonutrition can reduce acute toxicity in pancreatic cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pancreatic Cancer, Neoadjuvant Chemoradiotherapy | NA | Status: RECRUITING